Litigation Details for IN RE: COPAXONE ANTITRUST LITIGATION (D.N.J. 2022)
✉ Email this page to a colleague
IN RE: COPAXONE ANTITRUST LITIGATION (D.N.J. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-03-07 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 15:15 Antitrust Litigation | Assigned To | Susan Davis Wigenton |
| Jury Demand | Plaintiff | Referred To | Cathy L. Waldor |
| Patents | 8,232,250; 8,399,413; 8,969,302; 9,155,776; 9,402,874 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in IN RE: COPAXONE ANTITRUST LITIGATION
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for IN RE: COPAXONE ANTITRUST LITIGATION (D.N.J. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-04-29 | 31 | Amended Complaint | current daily Copaxone® 30 U.S. Patent Nos. 8,232,250; 8,399,413; 8,969,302; 9,155,776 ; and 9,402,874…expiries in 2035: U.S. Patent Nos. 9,155,775 (’775 patent) and 9,763,993 (’993 patent). …applicant for patent infringement. 44. If the brand manufacturer initiates a patent infringement…engineered a product “hop” from one non-patent covered product to another patent-covered product to move patients…competing Copaxone 13 The patents covering Copaxone 20mg were U.S. Patents Nos. 5,981,589; 6,054,430; | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
